Biering-Sorensen, T., Teerlink, J. R., Minamisawa, M., Felker, G. M., McMurray, J. J., Malik, F., … Solomon, S. (2019). The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Diastolic Filling and Function in Chronic Systolic Heart Failure (COSMIC-HF). In CIRCULATION (Vol. 140).

Biering-Sorensen, Tor, John R. Teerlink, Masatoshi Minamisawa, Gary Michael Felker, John J. McMurray, Fady Malik, Steven R. Goldsmith, Christopher Kurtz, and Scott Solomon. “The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Diastolic Filling and Function in Chronic Systolic Heart Failure (COSMIC-HF).” In CIRCULATION, Vol. 140, 2019.

Biering-Sorensen T, Teerlink JR, Minamisawa M, Felker GM, McMurray JJ, Malik F, et al. The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Diastolic Filling and Function in Chronic Systolic Heart Failure (COSMIC-HF). In: CIRCULATION. 2019.

Biering-Sorensen, Tor, et al. “The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Diastolic Filling and Function in Chronic Systolic Heart Failure (COSMIC-HF).” CIRCULATION, vol. 140, 2019.

Biering-Sorensen T, Teerlink JR, Minamisawa M, Felker GM, McMurray JJ, Malik F, Goldsmith SR, Kurtz C, Solomon S. The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Diastolic Filling and Function in Chronic Systolic Heart Failure (COSMIC-HF). CIRCULATION. 2019.